CD24 and pancreatic neoplasm: In the pancreatic cancer cells L3.6pl contained 59.1% CD24+/CD44+ cells of which 94.9% were EpCAM+/CD166+, yielding a 56.1% CSC subset (Figure 1b, upper panel).